Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study.

Butt, A A

Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study. [electronic resource] - Alimentary pharmacology & therapeutics 07 2018 - 35-43 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2036

10.1111/apt.14799 doi


2-Naphthylamine
Aged
Anilides--administration & dosage
Antiviral Agents--therapeutic use
Benzimidazoles--administration & dosage
Carbamates--administration & dosage
Case-Control Studies
Cyclopropanes
Drug Therapy, Combination
Electronic Health Records--statistics & numerical data
Female
Fluorenes--administration & dosage
Glomerular Filtration Rate--drug effects
Hepatitis C, Chronic--complications
Humans
Lactams, Macrocyclic
Macrocyclic Compounds--administration & dosage
Male
Middle Aged
Proline--analogs & derivatives
Renal Insufficiency, Chronic--complications
Retrospective Studies
Ritonavir--administration & dosage
Sofosbuvir
Sulfonamides--administration & dosage
Sustained Virologic Response
Treatment Outcome
Uracil--administration & dosage
Uridine Monophosphate--administration & dosage
Valine
Assessment of Medication Adherence